Spanish Research Group led by Dr. Eduardo Anitua

BTI Biotechnology Institute is a leading Spanish multinational specializing in regenerative medicine and oral implantology. Founded and led by Dr. Eduardo Anitua, the company developed the patented PRGF-Endoret technology, an autologous platelet-rich plasma system used to accelerate tissue repair and regeneration. Their business spans dental implants, specialized surgical tools, and therapeutic applications of growth factors in fields such as orthopedics, dermatology, and ophthalmology. BTI is recognized for its intensive R&D focus, maintaining a high volume of scientific publications and patents in the field of regenerative therapies. The company operates globally, providing both medical devices and biological solutions for tissue engineering.